RedHill Biopharma Ltd. (RDHL) Ownership
RDHL ownership summary
as of October 18, 2026- Institutions
- 3.5% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 8.9M
- Float
- 4.2M shares available to trade
- Short interest
- 2.40% 211K shares short
- Days to cover
- 0.04 short interest down 10.2% vs prior month
- Institutions 3.48%
- Other investors 96.52%
RDHL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Yorkville Advisors Global, LP | 1.37% | 122K | $58,623 | −228,739 (−65.2%) | June 30, 2026 |
| 2 | Gagnon Securities LLC | 0.99% | 88K | $42,434 | — | June 30, 2026 |
| 3 | Citadel Advisors Llc | 0.73% | 65K | $31,354 | +44,648 (+216.0%) | June 30, 2026 |
| 4 | Rhumbline Advisers | 0.15% | 14K | $6,602 | +8,639 (+168.9%) | June 30, 2026 |
| 5 | Lido Advisors, LLC | 0.12% | 11K | $5,284 | +11,009 (0.0%) | June 30, 2026 |
| 6 | GAMMA Investing LLC | 0.08% | 6,957 | $3,339 | +273 (+4.1%) | June 30, 2026 |
| 7 | Citigroup Inc | 0.05% | 4,378 | $2,101 | +4,378 (0.0%) | June 30, 2026 |
| 8 | Federation des caisses Desjardins du Quebec | 0.04% | 3,388 | $1,626 | — | June 30, 2026 |
| 9 | Royal Bank of Canada | <0.01% | 351 | $168 | +351 (0.0%) | June 30, 2026 |
| 10 | UBS Group AG | <0.01% | 100 | $48 | −726 (−87.9%) | June 30, 2026 |
| 11 | Mercer Global Advisors Inc. | <0.01% | 50 | $24 | +50 (0.0%) | June 30, 2026 |
| 12 | SBI Securities Co Ltd | <0.01% | 15 | $7 | +11 (+275.0%) | June 30, 2026 |
| 13 | Morgan Stanley - Brokerage Accounts | 0.00% | 1 | $0 | — | June 30, 2026 |
| 14 | EverSource Wealth Advisors, LLC | 0.00% | — | — | −38 (−100.0%) | March 31, 2026 |
| 15 | Garton & Associates Financial Advisors LLC | 0.00% | — | — | −15 (−100.0%) | March 31, 2026 |
| 16 | Group One Trading, LLC | 0.00% | — | — | −4 (−100.0%) | March 31, 2026 |
| 17 | StoneX Group Inc | 0.00% | — | — | −14,481 (−100.0%) | June 30, 2026 |
| 18 | XTX Topco Ltd | 0.00% | — | — | −15,163 (−100.0%) | June 30, 2026 |
| 19 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −13,019 (−100.0%) | June 30, 2026 |
| 20 | Your Advocates Ltd., LLP | 0.00% | — | — | −19 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 69K shares and 9 cut 272K.
RDHL top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Yorkville Health Care Opportunities Cl F | <0.01% | 14 | $7 | — | February 28, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
RDHL insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | Gilead Raday | Sell | — | 15,740,000 | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
RDHL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns RDHL
Institutional investors own 3.5% of RedHill Biopharma's shares and insiders 0.00%. The largest holder is Yorkville Advisors Global, LP with 1.37% of the shares (122K), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 9 reduced their stake in the latest filings. Short interest is 2.40% of the float, or 0.04 days of average trading volume. The share count rose 289,336,610.2% since 2014.
Related: RDHL key metrics. See the RDHL stock overview for the latest quote and news.
RDHL ownership FAQ
Who owns the most RedHill Biopharma stock?
The largest shareholders of RedHill Biopharma are Yorkville Advisors Global, LP (1.37%), Gagnon Securities LLC (0.99%), Citadel Advisors Llc (0.73%), Rhumbline Advisers (0.15%), Lido Advisors, LLC (0.12%).
What percentage of RedHill Biopharma is owned by institutions?
Institutions hold 3.5% of RedHill Biopharma's shares outstanding; insiders hold 0.00%.
Which funds own RedHill Biopharma?
The largest fund holders of RedHill Biopharma are Yorkville Health Care Opportunities Cl F (<0.01%).
What is RedHill Biopharma's short interest?
211K shares of RedHill Biopharma were sold short, 2.40% of the float; at the average daily volume it would take 0.04 days to cover.
Are insiders buying or selling RedHill Biopharma?
Of the latest 1 reported insider transactions in RedHill Biopharma (since April 6, 2026), 0 were purchases and 1 were sales.
How many shares of RedHill Biopharma are outstanding?
RedHill Biopharma has 8.9M shares outstanding, of which 4.2M are in the public float.